Received Dec 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19-2 | COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) | PFIZER\BIONTECH | 7+ | NA0738 | IM / LA |
Site: Pain at Injection Site-Medium, Site: Shoulder Joint Injury (prolonged pain, tingling, etc.)-Medium, Systemic: Fever-Mild, Additional Details: Patient reports restricted mobility and pain when moving starting from the day vaccines were given and hasn't really stopped. Still an ongoing issue for patient. Patient went to medical clinic on 10/20/25 to address ongoing issue. Patient reported vaccine adverse event to pharmacy on 11/21/25 , Other Vaccines: VaccineTypeBrand: Boostrix Tdap; Manufacturer: Glaxosmithkline; LotNumber: F9K3L; Route: IM; BodySite: left arm; Dose: 1; VaxDate: 09/08/2025